Missed the Congress ? NO Problem

Prof. Oliver Dorigo

Department of Obstetrics and Gynecology, Stanford University, Stanford, California, USA

About this speaker

Dr. Dorigo's clinical responsibilities include the direction of the Gynecologic Oncology Clinical Care Program at Stanford Women’s Cancer Center and the conduction of Gynecologic Oncology clinical trials at Stanford. His research focus as the Director of the Mary Lake Polan Gynecologic Oncology Research Laboratory is the development of novel targeted therapy approaches for ovarian cancer, using cell culture systems, human tissues arrays and mouse models for ovarian cancer.

Talks

Scientific Session H: New Therapeutic Solutions in Gynecological Cancers

06 May 2023, 04:00 PM
Prof. Oliver Dorigo Prof. Jianyu Rao

Junshi Biosciences

Founded in December 2012, Junshi Biosciences (HKEX: 1877; SSE: 688180) is an innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapeutics.

Hemosure

We at Hemosure are proud to manufacture and sell the fastest-growing Immunological Fecal Immunochemical Test (FIT) and have established its place as an industry leader.

Incyte

Incyte is a global biopharmaceutical company that is focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of novel medicines.

Want to sponsor this event? Contact Us